Evidence map›Paper›PMID 30301217›Full record

ArticleMolecules (Basel, Switzerland)2018

Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives.

Eman M Flefel, Walaa I El-Sofany, Mahmoud El-Shahat, Arshi Naqvi, Eman Assirey

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Pyridine Compounds with Antimicrobial and Antiviral Activities.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Eman M FlefelDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Monawarah 1343, Saudi Arabia. emanmflefel@yahoo.com.
Walaa I El-SofanyDepartment of Photochemistry, Chemical Industries Research Division, National Research Centre, 33 EL-Bohouth St., Dokki 12622, Giza, Egypt. arshi_84@yahoo.com.
Mahmoud El-ShahatDepartment of Photochemistry, Chemical Industries Research Division, National Research Centre, 33 EL-Bohouth St., Dokki 12622, Giza, Egypt. eman_assirey@hotmail.com.
Arshi NaqviDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Monawarah 1343, Saudi Arabia. walaa.elsofany@gmail.com.
Eman AssireyDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Monawarah 1343, Saudi Arabia. mahmoudelshahat@gmail.com.
Taibah University · SANational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel pyridine and fused pyridine derivatives have been prepared starting from 6-(3,4-dimethylphenyl)-2-hydrazinyl-4-(thiophen-2-yl)-pyridine-3-carbonitrile

Indexed as

Acetic AcidAnti-Bacterial AgentsAnti-Infective AgentsBenzoatesCarbon DisulfideFormatesGlucosamineGlucose-6-PhosphateMicrobial Sensitivity TestsMolecular Docking SimulationPyrazolesPyridinesStructure-Activity RelationshipAcetic AcidAnti-Bacterial AgentsAnti-Infective AgentsBenzoatesbenzoyl chlorideCarbon DisulfideFormatesformic acidGlucosamineglucosamine 6-phosphateGlucose-6-PhosphatepyrazolePyrazolespyridinePyridinesantimicrobial activityantioxidant agentin silico molecular dockingpyridine–pyrazole hybridspyridotriazinetriazolopyridine

Identifiers

PMID30301217
PMCPMC6222704
OpenAlexW2894677841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.